Singh, Ishmeet

Singh, Ishmeet was paid $614K by Medicaid between Jan 2018 and Nov 2023, across 13 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 46% of everything it billed.

Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in Illinois

Rank by total paid#2 of 75

Median peer was paid$11K

This provider vs. median57×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	958	$25K
2019	1,133	$29K
2020	679	$19K
2021	451	$10K
2022	12,483	$492K
2023	828	$40K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	46%	3,824	2,452	$284K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	13%	2,198	1,560	$77K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	12%	3,243	2,098	$76K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	12%	2,292	1,908	$72K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	2,846	1,899	$71K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.6%	435	407	$10K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.6%	794	528	$10K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	1.5%	225	129	$9K
99152		<1%	577	438	$3K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	52	52	$2K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	<1%	18	18	$533.64
72275		<1%	12	12	$412.40

1 more codes

90674

<1%

16

$336.22

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.